Ali Syed 4

Accession 0001209191-18-042241

CIK 0001058057other

Filed

Jul 9, 8:00 PM ET

Accepted

Jul 10, 7:30 PM ET

Size

24.4 KB

Accession

0001209191-18-042241

Form 4

Period: 2018-07-06

Director

Transactions

Award
Common shares
2018-07-06+2,143,416→ 2,143,416 total
Award
Stock Options (right to buy)
2018-07-06+504,242→ 504,242 total
Exercise: $8.86From: 2018-07-06Exp: 2019-02-24→ Common shares (504,242 underlying)
Award
Stock option (right to buy)
2018-07-06+322,715→ 322,715 total
Exercise: $9.38From: 2018-07-06Exp: 2021-02-07→ Common shares (322,715 underlying)
Award
Stock options (right to buy)
2018-07-06+178,941→ 178,941 total
Exercise: $16.31From: 2018-07-06Exp: 2027-02-10→ Common shares (178,941 underlying)
Award
Common shares
2018-07-06+1,744,002→ 4,446,273 total
Award
Stock option (right to buy)
2018-07-06+224,315→ 224,315 total
Exercise: $12.12From: 2018-07-06Exp: 2023-02-11→ Common shares (224,315 underlying)
Award
Common shares
2018-07-06+558,855→ 2,702,271 total
Award
Stock option (right to buy)
2018-07-06+130,966→ 130,966 total
Exercise: $15.58From: 2018-07-06Exp: 2022-02-16→ Common shares (130,966 underlying)
Award
Stock option (right to buy)
2018-07-06+403,394→ 403,394 total
Exercise: $9.33From: 2018-07-06Exp: 2020-03-22→ Common shares (403,394 underlying)
Award
Restricted stock units
2018-07-06+9,975→ 9,975 total
→ Common shares (9,975 underlying)

Footnotes (6)

[F1]Received in exchange for 985,162 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
[F2]Received in exchange for 265,876 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
[F3]Received in exchange for 801,582 shares of Cavium, Inc. common stock in connection with the merger (the "Merger") of Cavium, Inc. into Marvell Technology Group Ltd. ("Marvell"). On the effective date of the Merger, the Reporting Person received the reported common shares of Marvell.
[F4]Each restricted stock unit ("RSU") represents a contingent right to receive one Marvell common share.
[F5]Vests 100% of shares on the earlier of the next annual general meeting of Marvell or June 28, 2019, the one year anniversary of the restricted stock unit grant.
[F6]Received in the Merger in exchange for employee stock options to acquire shares of Cavium, Inc. common stock.

Documents

1 file

MARVELL TECHNOLOGY GROUP LTD

CIK 0001058057

Entity typeother